bciflex Medical was founded in 2022 and is an innovative medical device company composed of a global team of top scientists in advanced materials, micro nano manufacturing, artificial intelligence, neuroscience, and an experienced enterprise management team. As a leading innovative enterprise in the field of invasive brain computer interfaces rooted in China, bciflex Medical focuses on developing a new generation of brain computer interface platforms based on invasive ultra-thin flexible electrodes.

bciflex Medical has established a flexible electrode, hardware system, software and decoding algorithm, and implant robot research and development laboratory. At the same time, it has also built a clinical grade micro nano processing workshop and GMP workshop of about 2000 square meters in Changping, with complete independent research and development, design, and mass production capabilities. Since its establishment, the company has focused on the research and development of high-throughput brain computer interface core technology. Currently, it has obtained more than 40 domestic and foreign patents, covering multiple fields of brain computer interface core technology.

bciflex Medical will always take "building a world leading next-generation brain computer interface platform" as its mission, continuously promoting product research and clinical translation. We believe that in the near future, bciflex Medical's next-generation invasive brain computer interface platform will provide patients with safer and more effective treatment plans, build a bridge between human brain intelligence and machine intelligence, and make the human brain stronger!